AU2001227532A1 - A core formulation - Google Patents

A core formulation

Info

Publication number
AU2001227532A1
AU2001227532A1 AU2001227532A AU2753201A AU2001227532A1 AU 2001227532 A1 AU2001227532 A1 AU 2001227532A1 AU 2001227532 A AU2001227532 A AU 2001227532A AU 2753201 A AU2753201 A AU 2753201A AU 2001227532 A1 AU2001227532 A1 AU 2001227532A1
Authority
AU
Australia
Prior art keywords
core formulation
formulation
core
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001227532A
Inventor
Akwete L. Adjei
Anthony J. Cutie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aeropharm Technology LLC
Original Assignee
Aeropharm Technology LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aeropharm Technology LLC filed Critical Aeropharm Technology LLC
Publication of AU2001227532A1 publication Critical patent/AU2001227532A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001227532A 2000-05-01 2001-01-02 A core formulation Abandoned AU2001227532A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US20123300P 2000-05-01 2000-05-01
US60201233 2000-05-01
US09703023 2000-10-31
US09/703,023 US6296874B1 (en) 2000-05-01 2000-10-31 Core formulation comprising troglitazone and abiguanide
PCT/US2001/000039 WO2001082904A1 (en) 2000-05-01 2001-01-02 A core formulation

Publications (1)

Publication Number Publication Date
AU2001227532A1 true AU2001227532A1 (en) 2001-11-12

Family

ID=26896537

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001227532A Abandoned AU2001227532A1 (en) 2000-05-01 2001-01-02 A core formulation

Country Status (3)

Country Link
US (1) US6296874B1 (en)
AU (1) AU2001227532A1 (en)
WO (1) WO2001082904A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030153607A1 (en) * 1998-11-12 2003-08-14 Smithkline Beecham P.L.C. Novel composition and use
US20040102486A1 (en) * 1998-11-12 2004-05-27 Smithkline Beecham Corporation Novel method of treatment
US20040081697A1 (en) * 1998-11-12 2004-04-29 Smithkline Beecham P.L.C. Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent
MY125516A (en) * 1999-11-16 2006-08-30 Smithkline Beecham Plc Novel composition based on thiazolidinedione and metformin and use
US6524621B2 (en) * 2000-05-01 2003-02-25 Aeropharm Technology Inc. Core formulation
US6461639B2 (en) * 2000-05-01 2002-10-08 Aeropharm Technology, Inc. Core formulation
KR200249057Y1 (en) * 2001-03-22 2001-10-19 김진환 Sewage backflow integrated into the lid and base. Odor Prevention Device
FR2832633B1 (en) * 2001-11-28 2004-09-24 Lipha PHARMACEUTICAL COMPOSITION COMPRISING A METFORMIN ASSOCIATION AND A 4-OXO-BUTANOIC ACID AND ITS USE FOR TREATING DIABETES
US20030187074A1 (en) * 2002-03-04 2003-10-02 Javed Hussain Oral compositions for treatment of diabetes
AU2002356419A1 (en) 2002-06-17 2003-12-31 Themis Laboratories Private Limited Multilayer tablets containing thiazolidinedione and biguanides and methods for producing them
US8268352B2 (en) * 2002-08-05 2012-09-18 Torrent Pharmaceuticals Limited Modified release composition for highly soluble drugs
US8216609B2 (en) * 2002-08-05 2012-07-10 Torrent Pharmaceuticals Limited Modified release composition of highly soluble drugs
US9060941B2 (en) * 2002-09-20 2015-06-23 Actavis, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US7959946B2 (en) 2002-09-20 2011-06-14 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US8084058B2 (en) 2002-09-20 2011-12-27 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US7785627B2 (en) * 2002-09-20 2010-08-31 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US20040086566A1 (en) * 2002-11-04 2004-05-06 Alpharma, Inc. Waxy matrix dosage forms
IN192749B (en) * 2002-11-15 2004-05-15 Ranbaxy Lab Ltd
UA86015C2 (en) * 2003-01-29 2009-03-25 Такеда Фармасьютикал Компани Лимитед Process for producing coated preparation
FR2850576B1 (en) * 2003-02-05 2007-03-23 Ethypharm Sa COMPOSITION COMPRISING A MIXTURE OF ACTIVE INGREDIENTS AND PROCESS FOR PREPARING THE SAME

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW438587B (en) * 1995-06-20 2001-06-07 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
US6011049A (en) * 1997-02-19 2000-01-04 Warner-Lambert Company Combinations for diabetes
EP1039890B1 (en) * 1997-12-08 2004-03-17 Bristol-Myers Squibb Company Novel salts of metformin and method

Also Published As

Publication number Publication date
US6296874B1 (en) 2001-10-02
WO2001082904A1 (en) 2001-11-08

Similar Documents

Publication Publication Date Title
AU2001231229A1 (en) A system-on-a-chip
AU2001227535A1 (en) A core formulation
AU2001263348A1 (en) Slot core transformers
AU2002214471A1 (en) Map-aided positioning
AU2001289191A1 (en) Stator core design
AU2001227532A1 (en) A core formulation
AUPR054400A0 (en) A castor
AUPQ637600A0 (en) A superconducting transformer
AU2001286400A1 (en) Fiber formulation
AU2542301A (en) A planar transformer
AUPR000900A0 (en) A berley dispenser
AUPQ643100A0 (en) A toothbrush
EP1429732A4 (en) A core formulation
AU2001287962A1 (en) A ball
AUPR099200A0 (en) New formulation
AUPQ895200A0 (en) A mill
AU2002212379A1 (en) Core structure
GB0013400D0 (en) A formulation
AU2701301A (en) A kiosk
AUPQ680300A0 (en) A method
AU2002216484A1 (en) A brush
AUPR194200A0 (en) A method-ii
AUPQ645400A0 (en) A ligand - II
AU2002222119A1 (en) Dispenser
AU2001276477A1 (en) A game